T-3 Molecular Genetics (T-3 Mgen) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.11 M
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
About T-3 Molecular Genetics (T-3 Mgen)
T-3 Molecular Genetics (T-3 Mgen) Private Limited (TMGTMPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 20 July 2021 (Three years and six months 21 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Narendra Dhele, Shankarrao Patil, and Nameirakpam Singh serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U73100KA2021PTC149735
-
Company No.
149735
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Jul 2021
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at T-3 Molecular Genetics (T-3 Mgen)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Dhele
|
Director | 20-Jul-2021 | Current |
|
Nameirakpam Singh
|
Director | 20-Jul-2021 | Current |
|
Shankarrao Patil
|
Director | 20-Jul-2021 | Current |
Financial Performance of T-3 Molecular Genetics (T-3 Mgen).
T-3 Molecular Genetics (T-3 Mgen) Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of T-3 Molecular Genetics (T-3 Mgen)?
Unlock access to T-3 Molecular Genetics (T-3 Mgen)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
T-3 Agrotech Private LimitedNarendra Dhele is a mutual person
-
Dhriti Global Education Network Private Limited
Shankarrao Patil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at T-3 Molecular Genetics (T-3 Mgen)?
T-3 Molecular Genetics (T-3 Mgen) has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of T-3 Molecular Genetics (T-3 Mgen), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped T-3 Molecular Genetics (T-3 Mgen)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.